7. Immune Mechanisms of DB Flashcards
Type 1 DM can be immune mediated or idiopathic. Immune mediated type 1 DM is d/t what?
B-cell destruction.
Both will result in insulin dependence, with a loss of B-cells.
What is Type 2 DM?
Insulin resistance and relative insulin deficiency.
What is the clinical distinction for type 2 DM?
Oral hypoglycemic agents only work early in the disease process.
What are the mechanisms for T2D?
- B cells loss
- Decrease in B cell mass
- Decrease in Insulin-secretion
What are the causes of T2D?
Insulin resistance and glucotoxicity cause B-cells to overwork and failure, leading to overt and late T2D.
T2D is caused by ____________ in both the ________ and ______ that results in the development in the disease.
Chronic infllmation
Adipose tissue
& pancreas
T2D is characteristized by what 3 things?
- Hyperglycemia
- Insulin resistance
- Impairment in insulin secretion
T2D patients. have elevated blood sugar, resulting in what four things?
What contributes to the development of the disease?
- Renal failure, CAD, blindness and stroke.
- Genetic and lifestyle factors.
In patients that are normal-weight and nondiabetic, insulin secretion will result in
____ serum insulin
____ serum glucose
____ serum FFA
_____ IL-1B
_____ IL-1R ANT
Low
Low
Low
Low
HIGH
Insulin-sensitive individuals (norma), normal insulin secretion will do what:
_______ uptake of glucose from the circulation by skeletal. m and adipose tissue.
________ FFA release from adipose tissue
________ hepatic gluconeogenesis.
increase
inhibit
supress
In insulin-sensitive individuals, when insulin is secreted, how do adipose tissue macrophasges and kupffer cells react?
- Express IL-1 receptor antagonic
- Supress IL-1B
What is obesity characterized by and why is it linked to T2D?
Obesity causes chronic activation of inflammatory pathways.
Inflammation in obesity is linked to insulin resistance.
As we go from lean -> onset. of obsity ->chronic obesity, what changes?
we will start to express more immune cells in our adipose tissue;.
When we are lean, we have mostly [m2 macrophages, T-reg cells, Th2 cells and eosinophils].
- In chronic obesity, we. have mostly [m1 macrophages, Th1 cells, CTLs and neutrophils].
Obesity causes changes in adipocyte metabolism and gene expression.
Under lean-conditions (insulin-sensitive), what do adipocytes secrete?
Adipocytes will secrete
- Anti-inflammatory FFA (short-chain), IL-13 and IL-4.
- Those will then cause alternative activation of M2 MO, which secrete anti-inflammatory cytokines like IL-10, which will also inhibit M1 MO activation.
Obesity causes changes in adipocyte metabolism and gene expression.
Under obesity-conditions (insulin-resistant), what do adipocytes secrete?
Adipocytes will secrete
- Proinflammatory FFA (long and medium-chain FA)
- MCP-1 and TNF-alpha, which activate M1 MO.
M1 MO will then release pro-inflammatory mediatorys such as TNF-alpha, IL-1B, IL6, NO that act on adipocytes to cause insulin-resistance.
In T2D who are insulin-resistance, how do B-cells die?
Stressed beta cells will release insulin into bloodstream; resulting in:
- high serum insulin
- High serum glucose
- High serum FA
- High serum IL-1B
- Low serum IL-1Ra
That will result in glucotoxicity, lipotoxicity. and IL-1B toxicity -> [recruitment of MO, islet inflammation, increase antigen presentation and B-cell specific CTL licesnsing] -> B cell death.
In obsese patients, adipose tissues release __________, a _____- chain FFA. What happens next?
Palmitate, a long-chain FFA.
- B-cells in the pancreas sense palmitate via the TLR4-myD88 and recruit inflammatory monocytes to islets via chemokines.
- Monocytes–> M1 MO.
- M1 MO will -> increase inflammation, increase Ag presentation, activate cytoxic T-cells.
M2 MO and M1 are counterbalancings. M1 produces TNF and IL12, which stimulates NK cells to make INF-y.
M2 MO produces IL-10, which inhibit M1 MO.
IL-1 makes TNF and IFN-y –> + activate M1
Th2–> IL10, 4, 5 13. IL4, 13 and 10 will + M2 MO
T2D is a multifactorial disease, arising from the presence of T2D risk alleles and a disease-conducive environment. 52 common varients have been identified.
The lifetime risk for developing T2D if one parent has T2D is ____, and _____ when both parents have T2D.
40%
70%
What is the concordance rate of T2D in MZ twins and DZ twins?
MZ- 34%
DZ- 16%
________ have a 10 fold higher prevalence of T2D than general U.S population.
PIMA INDIANS
Twin studies show an important role in environmental and behavorial factors in developing T2D. Senendary life-styles and high fat diets can also cause it.
What is an environmental risk-factor?
Pollution; trafffic pollution. and pesticides, herbicides.
What is the role of microflora in T2D?
Weight gain–> increase intestinal microbiota (firmicutes/ bacteroidetes ratio) -> inflammation and insulin resistance.
There is a ______ relationship between intestinal microbiota and metabolic health.
recipricol.
What can be a Tx for insulin resistance and type 2 DM?
Faecal transplation (butyrate producing bacteria)
What is T1D?
Chronic autoimmune disease where by T-cells destroy pancreatic B-cell, causing insulin deficiency.
Insulin is one of the key target Ags recognized by auto-reactive T-cells, which destroy our B-cells. In 1965, pancreatic islet. inflammation was a hallmark of recent onset T1D. This was then followed by what?
Auto-antibodies, which became the first biomarker of T1D, which target insulin.
In the 1980s, it was established that T1D is d/t what?
Autoreactive T-lymphocytes and auto-antibodies that target insulin.
DB was considered a terminal condition before insulin was available for therapy.
In Jan 11, 1922, a 14yo boy became the 1st recipient of insulin.
Patients with T1D are prone to ________ and most cases are characterized by _____________ markers of what?
Patients with T1D are prone to ketoacidosis and most cases are characterized by auto-ab markers that. cause B-cell destruction and strong HLA associations.
At the time clinical sx of T1D show, _____ of the B-cells are destroyed.
Onset of T1D is associated with __________ infiltrating of the islets of langerhans.
60-80%.
Mononuclear cells and CD8+ Tcells (insulitis)